This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.CG Hayes . West Nile virus: Uganda, 1937, to New York City, 1999. Annals of the New York Academy of Science 2001; 951: 25–37.
3.LR Petersen , JT Roehrig . West Nile Virus: a reemerging global pathogen. Emerging Infectious Diseases 2001; 7: 611–614.
4.BP Granwehr , West Nile virus: where are we now? Lancet Infectious Diseases 2004; 4: 547–556.
5.S Higgs , K Snow , E Gould . The potential for West Nile virus to establish outside of its natural range: a consideration of potential mosquito vectors in the United Kingdom. Transcripts of the Royal Society of Tropical Medicine and Hygiene 2004; 98: 82–87.
6.KM Heinz-Taheny , West Nile virus infection in free-ranging squirrels in Illinois. Journal of Veterinary Diagnostic Investigation 2004; 16: 186–90.
7.1.DL Miller , West Nile virus in farmed alligators. Emerging Infectious Diseases 2003; 9: 794–9.
9.TF Tsai , West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352: 767–771.
10.AE Platonov , Outbreak of West Nile virus infection, Volgograd region, Russia, 1999. Emerging Infectious Diseases 2001; 7: 128–132.
11.RS Lanciotti , Complete genomic sequences and phylogenetic analysis of West Nile strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298: 96–105.
13.BJ Biggerstaff , LR Petersen . Estimated risk of West Nile virus transmission through transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019–1026.
16.D Nash , The outbreak of West Nile virus infection in the New York City area in 1999. New England Journal of Medicine 2001; 344: 1807–1814.
17.CDC.Outbreak of West Nile-like viral encephalitis – New York, 1999. Morbidity and Mortality Weekly Report 1999; 48: 845–849.
18.XY Jia , Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet 1999; 354: 1971–1972.
19.RS Lanciotti , Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286: 2333–2337.
20.GL Campbell , West Nile Virus. Lancet Infectious Disease 2002; 2: 519–529.
21.H Artsob , West Nile Virus in the New world – trends in the spread and proliferation of West Nile virus in the New World. Zoonoses and Public Health 2009; 56: 357–369.
25.N Komar , GG Clark . West Nile virus activity in Latin America and the Caribbean. Revista Panamericana Salud Publica 2006; 19: 112–117.
26.F Mostashari , Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261–264.
27.JA Brown , West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector-Borne and Zoonotic Diseases 2007#x003B; 7: 479–488.
28.RB Craven , JT Roehrig . West Nile Virus. Journal of the American Medical Association 2001; 344: 1858–1859.
29.R Brilla , Clinical and neuroradiologic features of 39 consecutive cases of West Nile virus meningoencephalitis. Journal of Neurological Sciences 2004; 220: 37–40.
30.EB Hayes , Virology, pathology and clinical manifestations of West Nile virus disease. Emerging Infectious Diseases 2005; 11: 1174–1179
31.JT Watson , Clinical characteristics and functional outcomes of West Nile Fever. Annals of Internal Medicine 2004; 141: 360–365.
32.DS Asnis , The West Nile virus encephalitis outbreak in the United States (1999–2000): from Flushing, New York, to beyond its borders. Annals of the New York Academy of Science 2001; 951: 161–171.
33.KO Murray , Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002–2004. Vector Borne and Zoonotic Diseases 2008; 8: 167–74.
34.JJ Sejvar , MB Haddad , BC Tierney . Neurologic manifestations and outcome of West Nile virus infection. Journal of the American Medical Association 2003; 290: 511–515.
35.S Ahmed , Guillain-Barré syndrome: an unusual presentation of West Nile Virus infection. Neurology 2000; 55: 144–146.
37.LE Davis , West Nile neuroinvasive disease. Annals of Neurology 2006; 60: 286–300.
38.M Saad , Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. Journal of Infection 2005; 51: 120–127.
39.LJ Johnston , GM Halliday , NJ King . Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. Journal of Investigative Dermatology 2000; 114: 560–568.
40.KM Chung , Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. Journal of Virology 2007; 81: 9551–5.
41.S Daffis , Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathogen 2007; 3: e106.
42.MP Busch , Virus and antibody dynamics in acute West Nile virus infection. Journal of Infectious Diseases 2008; 198: 984–93.
44.JT Roehrig , Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerging Infectious Diseases 2003; 9: 376–379.
45.H Kapoor , Persistence of West Nile virus IgM antibodies in cerebrospinal fluid from patients with CNS disease. Journal of Clinical Virology 2004; 31: 289–291.
46.AR Sambol , SH Hinrichs . Evaluation of a new West Nile virus lateral-flow rapid IgM assay. Journal of Virological Methods 2009; 157: 223–226.
47.N Komar , S Langevan , TP Monath . Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera. Clinical Vaccine Immunology 2009; 16: 134–135.
48.M Niedrig , Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. Journal of Virological Methods 2007; 139: 103–105.
50.MP Busch , Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. New England Journal of Medicine 2005; 353: 516–517.
51.PAG Tilley , Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. Journal of Infectious Diseases 2006; 193: 1361–1364.
53.AV Bode , West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clinical Infectious Disease 2006; 42: 1234–1240.
54.CM Jean 2007: Risk factors for West Nile virus neuroinvasive disease, California. Emerging Infectious Diseases 2005; 13: 1918–1920.
55.KO Murray , Risk factors for encephalitis from West Nile Virus: a matched case-control study using hospitalized controls. Zoonoses Public Health 2009; 56: 370–375.
57.D Kumar , Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004; 77: 399–402.
58.AG Freifeld , Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transplant Infectious Disease. Published online: 22 October 2009. doi:10.111/j.1600-6143.2004.00592.x
59.A Labowitz Klee , Long-term prognosis for clinical West Nile virus infection. Emerging Infectious Diseases 2004; 10: 1405–1411.
60.K Gottfried , R Quinn , T Jones . Clinical description and follow-up investigation of human West Nile virus cases. Southern Medical Journal 2005; 98: 603–606.
61.M Loeb , Prognosis after West Nile virus infection. Annals of Internal Medicine 2008; 149: 232–241.
62.RL Cook , Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. American Journal of Tropical Medicine and Hygiene 2010; 83: 1133–1136.
63.JJ Sejvar , West Nile virus-associated flaccid paralysis outcome. Emerging Infectious Diseases 2006; 12: 514–516.
64.KO Murray , M Resnick , V Miller . Depression after infection with West Nile virus. Emerging Infectious Diseases 2007; 13: 479–481.
65.VV Pogodina , Study on West Nile virus persistence in monkeys. Archives of Virology 1983; 75: 71–86.
66.RB Tesh , SY Xiao . Persistence of West Nile Virus infection in vertebrates. In: MS Diamond , ed. West Nile Encephalitis Virus Infection. New York: Springer, 2009, pp. 361–377.
67.V Siddharthan , Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. Journal of Virology. Published online: 18 February 2009. doi:10.1128/JVI.00017-09.
68.RB Tesh , Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. Journal of Infectious Disease 2005; 192: 287–295.
70.X Wu , Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters. Journal of Genetic Virology 2008; 89: 3073–3079.
71.KK Appler , Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS ONE 2010; 5:e10649, 1–12.
72.K Murray , Persistent infection with West Nile virus years after initial infection. Journal of Infectious Disease 2010; 201: 2–4.
73.RG Penn , Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clinical Infectious Disease 2006; 42: 680–683.
74.I Jordan , Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. Journal of Infectious Disease 2000; 182: 1214–1217.
75.M Enserink . Infectious disease: West Nile drugs, vaccine still years away. Science 2000; 290: 1483.
76.A. Anwar West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response. Virology 2005; 332: 66–77.
77.A Maeda , A PCR-based protocol for the generation of a recombinant West Nile virus. Virus Research 2009; 144: 35–43.
78.TP Monath , West Nile virus vaccine. Current Drug Targets – Infectious Disorders 2001; 1: 37–50.
79.B Guy , Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine 2010; 28: 632–649.
80.RB Tesh , Immunization with heterologous flavivirus protective against fatal West Nile encephalitis. Emerging Infectious Diseases 2002; 8: 245–251.
81.KM Chung , Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. Journal of Virology 2006; 80: 1340–1351.
82.Z Shimoni , Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerging Infectious Diseases 2001; 7: 759.
83.A Hamdan , Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile encephalitis. Transplant Infectious Disease 2002; 4: 160–162.
84.D Ben-Nathan , Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infectious Diseases 2009; 9: 18.